Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Lumos Pharma Inc. (LUMO)

13.86   0.04 (0.29%) 10-01 09:38
Open: 14.295 Pre. Close: 13.82
High: 13.86 Low: 13.86
Volume: 7 Market Cap: 115M
Lumos Pharma, Inc., formerly NewLink Genetics Corporation, is a clinical stage biopharmaceutical company. The Company is focused on the development and commercialization of therapeutics for rare diseases. Its lead product candidate is LUM-201, an oral growth hormone stimulating therapeutic, is in late stage clinical development for the treatment of Pediatric Growth Hormone Deficiency (PGHD). LUM-201 is an orally administered small molecule that promotes the secretion (secretagogue) of Growth Hormone (GH) from the pituitary gland. LUM-201 acts as an agonist of the GH Secretagogue Receptor to stimulate GH release. The Company’s pipeline features development programs in rare diseases associated with growth hormone deficiencies.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 14.1 - 14.179 14.179 - 14.251
Low: 13.304 - 13.406 13.406 - 13.5
Close: 13.928 - 14.08 14.08 - 14.219

Technical analysis

as of: 2020-09-30 4:43:50 PM
Stoxline posted a BUY today, upgraded from lower rating. Upward movement to be expected.
Target: Six months: 17.21     One year: 18.10
Support: Support1: 13.51    Support2: 11.24
Resistance: Resistance1: 14.74    Resistance2: 15.50
Pivot: 14.36
Moving Average: MA(5): 13.89     MA(20): 14.48
MA(100): 14.65     MA(250): 7.82
MACD: MACD(12,26): -0.28     Signal(9): -0.21
Stochastic oscillator: %K(14,3): 21.48     %D(3): 18.16
RSI: RSI(14): 43.41
52-week: High: 17.50  Low: 0.82  Change(%): 1054.3
Average Vol(K): 3-Month: 2802  10-Days: 1657

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.
LUMO has closed above bottom band by 32.9%. Bollinger Bands are 43.4% narrower than normal. The narrow width of the bands suggests low volatility as compared to LUMO's normal range. The bands have been in this narrow range for 28 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Thu, 13 Aug 2020
Lumos Pharma, Inc. (LUMO) Tops Q2 EPS by 6c -

Thu, 13 Aug 2020
Lumos Pharma Reports Second Quarter 2020 Results and Provides Update on Clinical and Corporate Activities - GlobeNewswire

Thu, 13 Aug 2020
Lumos Pharma, Inc. (LUMO) CEO Rick Hawkins on Q2 2020 Results - Earnings Call Transcript - Seeking Alpha

Tue, 28 Jul 2020
Analyst Rating: Will Lumos Pharma Inc (LUMO) Stock Outperform the Market? - InvestorsObserver

Mon, 27 Jul 2020
Lumos Pharma Announces Sale of Priority Review Voucher - GlobeNewswire

Wed, 10 Jun 2020
Is Lumos Pharma, Inc. (LUMO) A Good Stock To Buy? - Yahoo Finance

Financial Analysis

Growth n/a
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability n/a
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency n/a
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency n/a
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Outperform Discounted cash flow: Outperform
Return on Assets: Neutral Price to Earnings: Underperform
Return on Equity: Neutral Debt to Equity: Neutral
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 8
Shares Float (M)
% Held by Insiders 13.00
% Held by Institutions 39.99
Shares Short (K) 192
Shares Short P. Month (K) 190

Stock Financials

EPS Est This Year
EPS Est Next Year
Book Value (p.s.)
Profit Margin
Operating Margin
Return on Assets (ttm)
Return on Equity (ttm)
Qtrly Rev. Growth
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.) -1.103
Qtrly Earnings Growth
Operating Cash Flow (M) -8
Levered Free Cash Flow (M)

Stock Valuations

PE Ratio
PEG Ratio
Price to Book value
Price to Sales
Price to Cash Flow -14.03

Stock Dividends

Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2020 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.